Department of Community Medicine, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore, India.
Department of Health and Family Welfare, District Tuberculosis Office, Dakshina Kannada, Government of Karnataka, India.
J Epidemiol Glob Health. 2020 Dec;10(4):326-336. doi: 10.2991/jegh.k.200516.001. Epub 2020 May 23.
In India, ensuring all Persons with Presumptive TB (PPTB) undergo TB diagnostic tests and initiating all diagnosed TB patients on treatment are two major implementation challenges.
In a coastal district of Karnataka state, South India, to (1) determine the number and proportion of PPTB who did not undergo any TB diagnostic test, and the number and proportion of TB patients who were not initiated on treatment (2) explore the facilitators and barriers in TB diagnostic testing and treatment initiation from health care providers' perspective.
For objective-1, we used a cross-sectional design involving review of data of PPTB enrolled for care during January-March 2019 and for objective-2, we used a qualitative design involving key informant interviews of health care providers.
Of 8822 PPTB patients enrolled for evaluation of TB, 767 (9%) had not undergone any TB diagnostic test. In those who had undergone any TB diagnostic test, a total of 822 were diagnosed with TB and of them, 26 (3%) were not initiated on treatment. Cartridge-based nucleic acid amplification tests was used as a diagnostic test only among 1188 (13.5%) PPTB patients. The gaps in diagnostic testing were due to: non-availability of doctors/lab-technicians, inadequate knowledge about TB diagnostic tests among health care providers, reluctance of patients to undergo the TB diagnostic tests due to stigma/confidentiality issues and sub-optimal engagement of private health facilities for TB control.
About 9% of PPTB not undergoing any test for TB and 3% of the TB patients not initiated on treatment are of major concern. Revised National TB Control Programme needs to address the identified barriers to improve the process of TB diagnosis and treatment initiation.
在印度,确保所有疑似结核病患者(PTTB)接受结核病诊断检测并启动所有确诊结核病患者的治疗是两项主要的实施挑战。
在印度南部卡纳塔克邦的一个沿海地区,(1)确定未接受任何结核病诊断检测的 PPTB 人数和比例,以及未开始治疗的结核病患者人数和比例;(2)从卫生保健提供者的角度探讨结核病诊断检测和治疗启动的促进因素和障碍。
为实现目标 1,我们采用了横断面设计,回顾了 2019 年 1 月至 3 月期间登记接受结核病护理的 PPTB 数据;为实现目标 2,我们采用了定性设计,对卫生保健提供者进行了关键知情人访谈。
在登记接受结核病评估的 8822 名 PPTB 患者中,有 767 名(9%)未接受任何结核病诊断检测。在接受任何结核病诊断检测的患者中,共有 822 人被诊断患有结核病,其中 26 人(3%)未开始治疗。只有 1188 名(13.5%)PTTB 患者使用基于试剂盒的核酸扩增检测作为诊断检测。诊断检测中的差距是由于以下原因造成的:医生/实验室技术人员短缺、卫生保健提供者对结核病诊断检测的知识不足、患者因耻辱感/保密性问题不愿意接受结核病诊断检测以及私营卫生机构参与结核病控制的情况不理想。
约有 9%的 PPTB 未接受任何结核病检测,3%的结核病患者未开始治疗,这令人严重关切。修订后的国家结核病控制规划需要解决已确定的障碍,以改善结核病诊断和治疗启动的流程。